Table 8.
Data from patients with acute liver failure
|
Gender
|
Age
|
Outcome
|
COVID severity
|
Respiratory failure, SpO2, respiratory rate
|
O2
|
Laboratory tests
|
COVID complications
|
Comorbidities
|
| Male | 84 | Deceased | Critical | Yes, 83%, 18/min | No | ALT 107, ALP 117, GGT 107, LDH 743, Alb 29.3 | Sepsis; Electrolytes imbalance; Hypokalemia; Acid-alkaline imbalance | Heart disease; Epilepsy |
| Male | 55 | Deceased | Critical | Yes, 91%, 34/min | Yes | CRP 111, IL-6 87, ALT 115, AST 344, ALP 40, LDH 448, Alb 28.1 | Sepsis; Hypokalemia; Hyponatremia; Blood coagulation disorder | Primary hypertension; Obesity; Antibiotic resistance |
| Male | 44 | Recovered | Moderate | No, 94%, 16/min | No | CRP 98, IL-6 54, ALT 113, AST 193, ALP 73, GGT 355, LDH 399 | Hypokalemia | Primary hypertension; Heart disease; Kidney disease |
| Male | 42 | Deceased | Critical | Yes, 80%, 30/min | Yes | CRP 459, IL-6 99, ALT 162, AST 183, ALP 1183, GGT 67, LDH 900, Alb 16.6 | Acute kidney failure; Sepsis; Bacterial pneumonia complication; Hypokalemia; Blood coagulation disorder | Urinary tract infection; Anemia; Antibiotic resistance |
| Male | 50 | Deceased | Moderate | No, 98%, 22/min | No | CRP 221, IL-6 626, ALT 521, AST 53, ALP 296, GGT 559, LDH 546, Alb 16.5 | Acute kidney failure; Sepsis; Blood coagulation disorder; Hypokalemia | Heart disease; Cancer (lymphoma) |
COVID: Coronavirus disease; CRP: C-reactive protein; LDH: Lactate dehydrogenase; IL-6: Interleukine-6; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; GGT: Gamma-glutamyl transferase; ALP: Alkaline phosphatase; Alb: Albumin.